Vinva Investment Management Ltd Increases Position in UnitedHealth Group Incorporated $UNH

Vinva Investment Management Ltd boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 57,099 shares of the healthcare conglomerate’s stock after purchasing an additional 13,541 shares during the period. Vinva Investment Management Ltd’s holdings in UnitedHealth Group were worth $17,650,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nuveen LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $3,846,764,000. Vanguard Group Inc. grew its stake in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its position in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. Davis Selected Advisers grew its position in shares of UnitedHealth Group by 2,234.9% during the 2nd quarter. Davis Selected Advisers now owns 1,132,885 shares of the healthcare conglomerate’s stock valued at $353,426,000 after buying an additional 1,084,366 shares during the last quarter. Finally, National Bank of Canada FI raised its position in shares of UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after purchasing an additional 950,928 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $329.78 on Thursday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $622.83. The company has a market capitalization of $298.73 billion, a price-to-earnings ratio of 17.21, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock’s fifty day simple moving average is $343.60 and its 200-day simple moving average is $315.11.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter in the prior year, the company earned $7.15 EPS. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Analyst Ratings Changes

Several brokerages have weighed in on UNH. Mizuho lifted their target price on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. KeyCorp lifted their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Finally, Bank of America raised their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.